Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 7, 2011; 17(41): 4602-4606
Published online Nov 7, 2011. doi: 10.3748/wjg.v17.i41.4602
Table 3 Tumour recurrence and survival analyses
LGS(n = 22)OGS(n = 25)P value
Overall 5 yr mortality rate12 (54.5%)14 (56%)1
Cancer-related 5 yr mortality rate11 (50%)13 (52%)1
FU (5 yr) accomplishment20 (91%)23 (92%)1
Type of recurrence0.9
Port-site M0 (0%)
Locoregional/carcinosis2 (18%)4 (31%)
Hepatic M6 (55%)6 (46%)
Distant M3 (27%)3 (23%)
Median survival, mo (range)39 (12-60)38 (11-60)0.7
Disease free interval, mo (range)28 (12-60)26 (10-60)0.6